Workflow
Food Delivery
icon
搜索文档
BLOCK(SQ) - 2025 FY - Earnings Call Transcript
2025-06-18 04:00
分组1 - 公司2025年股东大会于6月17日下午3点以网络直播形式举行,旨在让股东广泛参与 [1][2] - 会议任命Chris Vico为选举监察员,负责检查和统计代理投票和选票 [4] - 会议记录日期为2025年4月21日,确定有权在本次会议投票的股东 [6] - 会议开始正式业务部分,将对2025年代理声明中的事项进行讨论并对代理提案进行投票 [5] - 投票方式为代理投票和在线投票,CDI持有人不能在本次会议投票 [8] - 会议有五项提案待股东审议和投票,包括选举三名一类董事、咨询批准高管薪酬、批准安永为独立注册会计师事务所、批准2025年股权激励计划、批准修订和重述的2015年员工股票购买计划 [9][10][11] - 初步投票结果显示,所有提案均获通过,最终投票结果将在选举监察员报告和会议记录中公布,并向美国证券交易委员会提交8 - K表格报告 [15][16] 分组2 - 无 分组3 - 无 分组4 - 无 分组5 - 无 分组6 - 会议回复可能包含前瞻性陈述,实际结果可能与预期有重大差异,报告结果不代表未来表现 [18] - 会议讨论的贷款和银行产品指通过Square Financial Services或银行合作伙伴提供的产品 [19] - 会议回复可能涉及非GAAP财务指标,与最直接可比的GAAP财务指标的对账信息可在股东信件、美国证券交易委员会文件或历史财务信息文件中获取 [19][20] 问答环节所有提问和回答 问题: 无 - 无
Odyssey Marine Exploration (OMEX) Conference Transcript
2025-06-18 03:55
Odyssey Marine Exploration (OMEX) Conference June 17, 2025 02:55 PM ET Speaker0 We have an update from Odyssey Marine Exploration Inc. Trades on the NASDAQ under the symbol o m e x. It's an ocean explorer committed to sustainable and responsible discovery, validation, and advancement of seafloor critical mineral projects, including polymetallic nodules for battery metals and subsea phosphate deposits for fertilizers. Happy to welcome back chairman and CEO, Mark Gordon. Welcome back, Mark. Speaker1 It's grea ...
Shell: Buybacks Make It A Hold, For Now
Seeking Alpha· 2025-06-18 03:53
Despite all the market uncertainty around Trump’s tariffs, offset now by the escalation of the Israel-Iran conflict, Shell (NYSE: SHEL ) is now back on track to reach a new all-time high fueled by significant buybacks. However, it’s these buybacksAs of 2025, I've got over 10 years of researching companies. In total, throughout my investing life, I estimate that I researched (in depth) well over 1000 companies, from commodities like oil, natural gas, gold and copper to tech like Google or Nokia and many emer ...
PayPal Is Too Cheap To Ignore
Seeking Alpha· 2025-06-18 03:50
PayPal (NASDAQ: PYPL ) has experienced a big sell-off in 2021 and 2022 mainly due to lower than anticipated growth, as the company didn't manage to keep their growth rates at historical rates in the range of 15% to 21%.German Buy-Hold-Check investor. With a master's degree in engineering and management, I am able to understand, quantify, and interpret both the economics and (to some point) the technology of companies.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of th ...
Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data?
Seeking Alpha· 2025-06-18 03:42
Having taken a look at Corbus Pharmaceuticals Holdings (NASDAQ: CRBP ) and coming away cautious just after a surge in value, the stock value more than doubled over the rest of 2024 before crashingI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this ...
U.S. Steel Stock Burns the Bears With Surprise Upside Move
MarketBeat· 2025-06-18 03:41
United States Steel TodayXUnited States Steel$54.82 -0.03 (-0.05%) 52-Week Range$26.92▼$54.91Dividend Yield0.36%P/E Ratio36.79Price Target$43.80Add to WatchlistEvaluating the sentiment in any underlying stock is as simple as checking who is buying (and how much) and who is selling. However, seeing unusual buying or selling activity is only half the equation; the other half is up to investors to figure out whether these buyers or sellers are right in their decisions to position themselves. Reverse engineeri ...
SAGE to be Acquired by Supernus Pharmaceuticals in $795 Million Deal
ZACKS· 2025-06-18 03:41
Key Takeaways Supernus will acquire SAGE for $8.50 per share plus CVR worth up to $3.50, totaling $795 million. The deal gives SUPN rights to Zurzuvae, the first oral postpartum depression drug, launched in late 2023. SUPN expects the acquisition to be accretive in 2026 and to broaden its neuroscience-focused portfolio.Sage Therapeutics (SAGE) announced that Supernus Pharmaceuticals (SUPN) has agreed to acquire SAGE through a tender offer of $8.50 per share in cash, totaling around $561 million. Additiona ...
Slowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?
ZACKS· 2025-06-18 03:41
Key Takeaways Gardasil sales fell 40% in Q1 2025 due to weak demand and high inventory levels in China. MRK paused China shipments from February 2025 as Zhifei works through excess inventory. MRK withdrew Gardasil's $11B sales goal by 2030, citing China's economic headwinds.Merck’s (MRK) second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human papillomavirus (HPV). Though the vaccine’s sales rose consistently till 2022, it started witnessing sluggish sal ...
JetBlue CEO: More Cuts Ahead As Airline Faces Prolonged Losses
Benzinga· 2025-06-18 03:39
JetBlue Airways Corp. JBLU CEO Joanna Geraghty told employees on Tuesday that the company is rolling out additional cost-saving measures due to weaker travel demand, making it unlikely the airline will reach break-even margins this year.Financial Outlook and ProfitabilityGeraghty expressed hope that demand and bookings might improve, but noted that even a rebound would not fully recover the losses experienced so far, according to CNBC. As a result, JetBlue continues to depend on borrowed funds to maintain o ...
Meta is reportedly building AI smart glasses with Prada, too
TechCrunch· 2025-06-18 03:38
核心观点 - Meta正与意大利高端时尚品牌Prada合作开发AI智能眼镜 [1] - 此次合作表明公司计划将AI智能眼镜技术拓展至EssilorLuxottica体系外的时尚品牌 [2] - 公司已售出数百万副Ray Ban Meta AI智能眼镜 并即将与EssilorLuxottica旗下Oakley品牌推出新品 [3] 合作动态 - Prada智能眼镜的具体发布时间尚未明确 [1] - Prada虽长期依赖EssilorLuxottica生产眼镜 但此次合作属于独立于该集团的直接合作 [2] - Oakley智能眼镜可能于本周五发布 售价约360美元 [3] 市场策略 - 通过Prada合作突破原有与EssilorLuxottica的独家合作模式 扩大时尚行业覆盖范围 [2] - 近期连续布局Ray Ban和Oakley两大EssilorLuxottica旗下品牌 显示多线并进策略 [3]